FGF21 and fatty liver disease: Wang further found that the injection of recombinant murine FGF21 reduces IL-6, TNF-α, and leptin mRNA levels in WAT of monosodium glutamate-induced obese rats, with the improvement of glucose tolerance, lipid metabolic spectrum, and hepatic steatosis (41).